Partnership to Improve Patient Care

  • Home
  • About
    • Mission and Priorities
    • Meet the Chairman
    • Steering Committee
    • PIPC Member List
    • Contact
  • The Issues
    • Value Our Health
    • International
    • Where We Stand
    • Value Assessment Frameworks
    • Engaging Patients in Value-Based Payment
    • Patient-Centeredness in Research
  • Resources
    • Advocacy
    • Letters and Comments
    • PCORI Meeting Transcripts
    • Polling
    • Roundtables
    • White Papers
  • Blog
    • PIPC Patients' Blog
    • Chairman's Corner
    • PIPC Weekly Update
    • The Data Mine
  • Newsroom
    • PIPC in the News
    • Press Releases
    • Open Letter: We Deserve a Voice
  • Events
    • PIPC Forum 2022
    • Discrimination & Health Care
    • C & GT Webinar
    • ICER COVID Webinar
    • Value Our Health Briefing
    • QALY Briefing
    • QALY Panel
    • Past Webinars >
      • ICER SCD Webinar
      • VOH Sickle Cell Webinar
      • Rare Disease Webinar
      • QALY Webinar
      • PCORI Advocacy Webinar
      • APM Webinar
      • Patient Empowerment Webinar
      • Value Assessments Briefing
    • Past PIPC Forums >
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
  • Home
  • About
    • Mission and Priorities
    • Meet the Chairman
    • Steering Committee
    • PIPC Member List
    • Contact
  • The Issues
    • Value Our Health
    • International
    • Where We Stand
    • Value Assessment Frameworks
    • Engaging Patients in Value-Based Payment
    • Patient-Centeredness in Research
  • Resources
    • Advocacy
    • Letters and Comments
    • PCORI Meeting Transcripts
    • Polling
    • Roundtables
    • White Papers
  • Blog
    • PIPC Patients' Blog
    • Chairman's Corner
    • PIPC Weekly Update
    • The Data Mine
  • Newsroom
    • PIPC in the News
    • Press Releases
    • Open Letter: We Deserve a Voice
  • Events
    • PIPC Forum 2022
    • Discrimination & Health Care
    • C & GT Webinar
    • ICER COVID Webinar
    • Value Our Health Briefing
    • QALY Briefing
    • QALY Panel
    • Past Webinars >
      • ICER SCD Webinar
      • VOH Sickle Cell Webinar
      • Rare Disease Webinar
      • QALY Webinar
      • PCORI Advocacy Webinar
      • APM Webinar
      • Patient Empowerment Webinar
      • Value Assessments Briefing
    • Past PIPC Forums >
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010

The PIPC Blog

PIPC Patient Blog: Migraine Patients Deserve Access to Needed Treatments

3/5/2020

 
Picture
By: Jaime Sanders 
​

​​I am a mother, wife, and patient advocate living with intractable migraine. I am allergic to or do not tolerate many standard migraine treatments, and the pain management options I am left with are extremely limited. Despite a comprehensive strategy to manage my migraine and taking four preventative medications, I am in pain every, single day. Living with migraine disease carries a huge burden. It has forced me to leave the work force and my husband and children to be caregivers. 
​This is not an uncommon story. According to the World Health Organization, migraine is the second leading cause of global disability. It disproportionately affects women and typically hits between ages of 30-49, our most productive years of work and raising a family. The societal cost that accompanies migraine disease is enormous. For this reason, it is essential that we are developing new, more effective treatments, for patients like me.
 
When I hear of novel treatments in development, like the recent approval of therapies called gepants, I am hopeful but cautious. I have been in this world long enough to know that as soon as a new drug is approved, payers will begin looking at their wallets and turn to third parties like the Institute for Clinical and Economic Review (ICER) for reasons they need not cover the drugs or should implement burdensome and harmful prior authorization strategies. In this instance - though I have serious concerns with ICER’s methodology that devalues my life as someone living with a chronic condition - I was heartened it found two of these new migraine treatments to be cost-effective. I am, however, simultaneously concerned that its recommendations to payers overtly recommend they use burdensome prior authorization criteria, which will lead to delays and barriers for patient access.
 
Migraine has been synonymous with my life since I can remember. At the age of eight, I was formally diagnosed and put on propranolol for prevention. I was on that medication for five years, but it never worked. At that early age, I learned that migraine is a capricious disease that is difficult to effectively treat. For this reason, it is vital to have good neurologists and headache specialists that know you and your migraine disease, and it is equally important that they are able to do their jobs and prescribe the treatment plan they know is best for their patients without forcing us to try numerous drugs that will not work. Migraine is a progressive disease, and delays lead to more costly migraine attacks and chronification. I know this personally.
 
Most of my life with migraine I was episodic, experiencing 3-10 migraine attacks per month with 1-2 being extremely severe. Then during my third pregnancy, something changed. My first trimester I had a three-month long migraine attack. At the time, I was working full-time, going to school at night, and had a three-year old and a nine-month old at home. Being in pain every single day was exhausting.  I assumed I had a brain tumor.  After an MRI that came back clear, the conclusion was that it was a migraine that would not go away due to hormones and the pregnancy. After that, the attacks became more severe and lasted longer.
 
I worked with my doctors and tried every treatment. Over the counter medications didn’t help, and I quickly found that I could not tolerate triptans. I tried several prevention medications, which would work for short periods of time before becoming ineffective.
 
My story is far too common. Patients like me should immediately access new treatments. To ensure this happens, it is vital that doctors’ assessments be widely accepted in determining which patients have failed or can’t use older medicines. Migraine disease is an incredibly personal journey and the clinician-patient relationship should be primary, not the academics over at ICER or their recommendations for prior authorization, in making treatment decisions. 

Comments are closed.

    Topics

    All
    Alternative Payment Models
    Chairman's Corner
    Patient Centered Research
    PIPC In The News
    PIPC Patient Blog
    PIPC Weekly Update
    Press Releases
    The Data Mine
    Value Frameworks

    Archives

    January 2023
    December 2022
    November 2022
    October 2022
    September 2022
    August 2022
    July 2022
    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    April 2013
    March 2013
    December 2012
    November 2012
    February 2012
    September 2011
    August 2011
    July 2011
    May 2011
    March 2011
    November 2010
    October 2010
    September 2010
    August 2010
    April 2010
    March 2010
    February 2010
    December 2009
    September 2009
    July 2009
    June 2009
    May 2009
    February 2009
    January 2009
    December 2008

About PIPC
The Issues
Resources
Blog
In the News
Press Releases
Contact Us
100 M Street, SE – Ste. 750
Washington, DC 20003